Cardinal Health, Inc.

Cardinal Health, Inc. is a US-based company specializing in healthcare solutions, logistics, and medical supplies, serving healthcare professionals and organizations with comprehensive products and services. Founded in 1971, Cardinal Health, Inc. operates primarily in Dublin, US, providing essential healthcare solutions.

In August 2025, Cardinal Health agreed to acquire a 75% majority stake in Solaris Health Holdings, LLC from Lee Equity Partners for approximately USD 1. 9 billion in cash. The company has expanded its offerings over the years to include a broader range of healthcare supplies and services critical to various healthcare sectors. It operates globally, with a focused presence in North America, Europe, Asia-Pacific, and Latin America.

The current CEO team includes Anuchit Janchong, Debbie Weitzman, Lisandro Diaz, Mike Kaufmann, Sohidul Islam, and Timothy Crawford. Cardinal Health specializes in providing a comprehensive range of healthcare solutions, logistics, and medical supplies to healthcare professionals and organizations globally. Their core product offerings include medical products and supplies, pharmaceutical products, and healthcare services. The company's medical supplies encompass a wide variety of items such as surgical instruments, personal protective equipment (PPE), lab supplies, and durable medical equipment (DME).

Pharmaceutical offerings consist of generic medications, biosimilars, and specialty distribution services aimed at improving patient care. Cardinal Health services clients across various sectors including hospitals, long-term care facilities, retail pharmacies, and home care providers, thereby addressing end-user needs through enhanced access to essential healthcare products. The company operates on a global scale, catering to markets in North America, Europe, Asia-Pacific, and Latin America, ensuring that their solutions are accessible to a diverse client base. Cardinal Health generates revenue through a multi-faceted transaction structure that includes business-to-business (B2B) sales, direct-to-consumer offerings, and partnerships with healthcare providers.

Transactions typically occur through a combination of wholesale distribution and direct sales, where healthcare facilities place orders for essential medical supplies and pharmaceuticals. For instance, a hospital may engage in a contract with Cardinal Health to supply surgical supplies and medications as part of their operational needs, leading to ongoing replenishment orders based on usage rates. The company’s revenue model may also encompass service agreements for inventory management solutions, where healthcare facilities pay for Cardinal Health's expertise in optimizing their supply chain. This diverse approach to revenue generation enables Cardinal Health to maintain a robust market presence while providing tailored solutions to meet the specific demands of its clients.

In August 2025, Cardinal Health agreed to acquire a 75% majority stake in Solaris Health Holdings, LLC from Lee Equity Partners for approximately USD 1. 9 billion in cash. The acquisition of Solaris Health Holdings, LLC will enable Cardinal Health to expand its platform and accelerate growth.